Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Director departure
Quarterly results
IMMUNE PHARMACEUTICALS INC (IMNPQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/12/2019 SC 13G Hughes Eric Olan reports a 6.2% stake in Immune Pharmaceuticals Inc.
06/28/2017 SC 13G Skidmore Brian reports a 4.1% stake in Immune Pharmaceuticals Inc.
03/19/2014 SC 13G MMCAP International Inc. SPC reports a 10% stake in IMMUNE PHARMACEUTICALS INC.
09/06/2013 SC 13G Forsakringsaktiebolaget Avanza Pension reports a 2.2% stake in Immune Pharmaceuticals Inc.
02/12/2013 SC 13G Forsakringsaktiebolaget Avanza Pension reports a 11.4% stake in EPICEPT CORPORATION
01/22/2013 SC 13G SABBY MANAGEMENT, LLC reports a 9.9% stake in EpiCept Corporation
02/13/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/31/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
11/01/2010 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
08/21/2008 SC 13G KOPIN MITCHELL P has filed a Schedule 13D for EpiCept Corporation
08/11/2008 SC 13G KOPIN MITCHELL P has filed a Schedule 13D for EpiCept Corporation
07/30/2008 SC 13G Enable Growth Partners L P reports a 6.1% stake in EpiCept Corporation.
07/30/2008 SC 13G Levine Mitchell S reports a 6.1% stake in EpiCept Corporation.
07/30/2008 SC 13G Enable Capital Management, LLC reports a 6.1% stake in EpiCept Corporation.
02/14/2007 SC 13G TVM III Limited Partnership reports a 13.7% stake in EpiCept Corporation
01/08/2007 SC 13G CORNELL CAPITAL PARTNERS LP reports a 7.4% stake in
01/05/2007 SC 13G DOMAIN PUBLIC EQUITY PARTNERS LP reports a 5.8% stake in EpiCept Corporation

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy